Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. May 15, 2022; 14(5): 1014-1026
Published online May 15, 2022. doi: 10.4251/wjgo.v14.i5.1014
Table 1 Patients’ characteristics between low-grade and high-grade malignant potential groups
Characteristics
Low-grade, n = 82
High-grade, n = 21
t or χ2 value
P value
Age in year58.57 ± 8.9057.28 ± 10.470.5700.570
Sex, n (%)0.3540.552
Male37 (45.1)11 (52.4)
Female45 (59.9)10 (47.6)
Largest diameter32.66 ± 8.7738.76 ± 9.092.8240.006a
Location, n (%)2.1090.550
Cardia2 (2.4)0 (0)
Fundus40 (48.8)12 (57.1)
Body28 (34.1)8 (38.1)
Antrum12 (14.6)1 (4.8)
Growth patterns, n (%)2.1960.334
Endoluminal39 (47.6)11 (52.4)
Exophytic24 (29.3)3 (14.3)
Mixed19 (23.2)7 (33.3)
Contour, n (%)4.6460.031a
Regular56 (68.3)9 (42.9)
Irregular26 (31.7)12 (57.1)
Margin, n (%)5.6450.018a
Well-defined67 (81.7)12 (57.1)
Poorly15 (18.3)9 (42.9)
Necrosis, n (%)4.2680.039a
Absent48 (58.5)7 (33.3)
Present34 (41.5)14 (66.7)
Calcification, n (%)0.6300.427
Absent75 (91.5)18 (85.7)
Present7 (8.5)3 (14.3)
Ulceration, n (%)7.8230.005a
Absent67 (81.7)11 (52.4)
Present15 (18.3)10 (47.6)
Plain CT value34.65 ± 37.9231.10 ± 13.230.4210.674
Arterial phase CT value63.70 ± 36.5059.81 ± 18.580.4710.639
Venous phase CT value71.78 ± 35.7663.43 ± 17.321.0350.303
Delayed phase CT value73.65 ± 34.9666.14 ± 14.390.9600.339